Case Study: Large Pharmaceutical Company improves oncology market positioning with Mu Sigma

Conducted market opportunity assessment for a large pharmaceutical company for identifying sales potential

Mu Sigma worked with a large pharmaceutical company that was developing two pipeline molecules for oncology indications across major geographies. The customer needed to reassess market opportunity and competitive positioning amid major oncology market changes, including new competitors, launches, secondary indications, and prior clinical trial suspensions that had affected development plans.

Mu Sigma built an opportunity assessment dashboard that combined competitive landscape analysis, competitor segmentation, regulatory and launch timelines, pricing benchmarks, and target product profile inputs. This gave the client a clear view of key competitors and market dynamics, helping refine product positioning and decision-making; the result was retained market share and a gradual increase in share over time.